What is NDC 72241-056?

72241-056 is the product NDC for Olanzapine, Olanzapine 20 mg/1 tablet, listed with the FDA by Modavar Pharmaceuticals LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.

Modavar Pharmaceuticals LLC, NDC labeler code 72241. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Olanzapine?

205 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Olanzapine NDC 72241-056 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72241-056Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72241-0056Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
72241-056-04	72241005604	100 TABLET in 1 BOTTLE (72241-056-04)Marketed from Jan 17, 2024
72241-056-10	72241005610	500 TABLET in 1 BOTTLE (72241-056-10)Marketed from Jan 17, 2024
72241-056-11	72241005611	1000 TABLET in 1 BOTTLE (72241-056-11)Marketed from Jan 17, 2024
72241-056-22	72241005622	30 TABLET in 1 BOTTLE (72241-056-22)Marketed from Jan 17, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Olanzapine
Generic name (nonproprietary): olanzapine
Active ingredients: Olanzapine — 20 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Modavar Pharmaceuticals LLCNDC labeler code 72241
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210022
Marketing start: Feb 27, 2023
Listing expires: Dec 31, 2027
Identifiers: Product ID 72241-056_750e2e2e-66d4-446d-9c90-cafcb3a4e926SPL ID 750e2e2e-66d4-446d-9c90-cafcb3a4e926SPL set ID f0943b4e-6bdc-48c1-8ecd-39cf732e16f5RxCUI 200034, 283639, 312077, 312078, 312079, 314154UNII N7U69T4SZRUPC 0372241053108, 0372241055225, 0372241056222, 0372241054105, 0372241056116, 0372241055119, 0372241054051, 0372241054112, 0372241052118, 0372241051050, 0372241051111, 0372241051104, 0372241053115, 0372241052101, 0372241056109
Pharmacologic class: Atypical Antipsychotic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472241005604 followed by a unit qualifier and the quantity

Package 72241-0056-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 6, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Olanzapine is an atypical antipsychotic indicated: As oral formulation for the: • Treatment of schizophrenia. ( 1.1 ) • Adults: Efficacy was established in three clinical trials in patients with schizophrenia: two 6-week trials and one maintenance trial. ( 14.1 ) • Adolescents (ages 13 to 17): Efficacy was established in one 6-week trial in patients with schizophrenia ( 14.1 ). The increased potential (in adolescents compared with adults) for weight gain and dyslipidemia may lead clinicians to consider prescribing other drugs first in adolescents. ( 1.1 ) • Acute treatment of manic or mixed episodes associated with bipolar I disorder and maintenance treatment of bipolar I disorder. ( 1.2 ) •…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72241-056

What is NDC 72241-056?: 72241-056 is the product NDC for Olanzapine, Olanzapine 20 mg/1 tablet, listed with the FDA by Modavar Pharmaceuticals LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Olanzapine.
What is the active ingredient?: Olanzapine.
Who is the labeler?: Modavar Pharmaceuticals LLC, NDC labeler code 72241. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Olanzapine?: 205 other product NDCs are listed under this name. See all Olanzapine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Olanzapine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Olanzapine	Olanzapine 5 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0690	67046-0690-03
Olanzapine	Olanzapine 2.5 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4729	70518-4729-00
Olanzapine	Olanzapine 2.5 mg/1	Tablet, Film coatedOral	Cardinal Health 107, LLC	55154-6693	55154-6693-00
olanzapine	Olanzapine 10 mg/1	Tablet, Orally disintegratingOral	Bionpharma Inc.	69452-562	69452-0562-13
olanzapine	Olanzapine 5 mg/1	Tablet, Orally disintegratingOral	Bionpharma Inc.	69452-561	69452-0561-13
olanzapine	Olanzapine 15 mg/1	Tablet, Orally disintegratingOral	Bionpharma Inc.	69452-563	69452-0563-13
olanzapine	Olanzapine 20 mg/1	Tablet, Orally disintegratingOral	Bionpharma Inc.	69452-564	69452-0564-13
Olanzapine	Olanzapine 10 mg/1	Tablet, Film coatedOral	Unit Dose Solutions, Inc.	87441-061	87441-0061-01
Olanzapine	Olanzapine 5 mg/1	Tablet, Film coatedOral	Unit Dose Solutions, Inc.	87441-062	87441-0062-01
Olanzapine	Olanzapine 20 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0072	67046-0072-03

All 206 Olanzapine NDCs

Other NDCs under ANDA 210022

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210022
Product	Strength	Form · route	Labeler	Product NDC
Olanzapine	Olanzapine 10 mg/1	TabletOral	Coupler LLC	67046-1583
Olanzapine	Olanzapine 20 mg/1	TabletOral	Coupler LLC	67046-1604
Olanzapine	Olanzapine 2.5 mg/1	TabletOral	Coupler LLC	67046-1611
Olanzapine	Olanzapine 10 mg/1	TabletOral	Cadila Pharmaceuticals Limited	71209-076
Olanzapine	Olanzapine 2.5 mg/1	TabletOral	Cadila Pharmaceuticals Limited	71209-073
Olanzapine	Olanzapine 5 mg/1	TabletOral	Cadila Pharmaceuticals Limited	71209-074
Olanzapine	Olanzapine 7.5 mg/1	TabletOral	Cadila Pharmaceuticals Limited	71209-075
Olanzapine	Olanzapine 15 mg/1	TabletOral	Cadila Pharmaceuticals Limited	71209-077
Olanzapine	Olanzapine 20 mg/1	TabletOral	Cadila Pharmaceuticals Limited	71209-078
Olanzapine	Olanzapine 5 mg/1	TabletOral	Modavar Pharmaceuticals LLC	72241-052
Olanzapine	Olanzapine 2.5 mg/1	TabletOral	Modavar Pharmaceuticals LLC	72241-051
Olanzapine	Olanzapine 7.5 mg/1	TabletOral	Modavar Pharmaceuticals LLC	72241-053
Olanzapine	Olanzapine 10 mg/1	TabletOral	Modavar Pharmaceuticals LLC	72241-054
Olanzapine	Olanzapine 15 mg/1	TabletOral	Modavar Pharmaceuticals LLC	72241-055
Olanzapine	Olanzapine 15 mg/1	TabletOral	Coupler LLC	67046-1653